Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effect of Fetuin A in Hemodialysis Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2006 by University of Shizuoka.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Maruyama Memorial General Hospital
Information provided by:
University of Shizuoka
ClinicalTrials.gov Identifier:
NCT00309426
First received: March 27, 2006
Last updated: May 18, 2006
Last verified: March 2006
  Purpose

The purpose of this study is to examined the effect of fetuin A on atherosclerosis and prognosis in hemodialysis patients.


Condition
Hemodialysis
Malnutrition

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Longitudinal
Official Title: The Effect of Serum Fetuin A Concentration on the 5-Year Prognosis in Hemodialysis Patients

Resource links provided by NLM:


Further study details as provided by University of Shizuoka:

Estimated Enrollment: 300
Study Start Date: March 2001
Estimated Study Completion Date: March 2006
Detailed Description:

Fetuin A is known to be a potent inhibitor of ectopic calcification in plasma, and the concentration of fetuin A is closely associated with protein nutritional status. The purpose of this study is to examine whether the plasma concentration of fetuin A is associated with atherosclerosis and 5-year prognosis in hemodialysis patients.

  Eligibility

Ages Eligible for Study:   up to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Hemodialysis for at least 6 months

Exclusion Criteria:

  • Disabled patients
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00309426

Locations
Japan
Maruyama Hospital
Hamamatsu, Shizuoka, Japan, 430-0001
Sponsors and Collaborators
University of Shizuoka
Maruyama Memorial General Hospital
Investigators
Study Chair: Hiromichi Kumagai, MD University of Shizuoka
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00309426     History of Changes
Other Study ID Numbers: CT2006003
Study First Received: March 27, 2006
Last Updated: May 18, 2006
Health Authority: Japan: Ministry of Health, Labor and Welfare

Keywords provided by University of Shizuoka:
atherosclerosis

Additional relevant MeSH terms:
Malnutrition
Nutrition Disorders

ClinicalTrials.gov processed this record on November 20, 2014